SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-129247
Filing Date
2023-12-26
Accepted
2023-12-26 17:05:30
Documents
1
Period of Report
2023-12-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2333705-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2333705-4_4seq1.xml 4 4014
  Complete submission text file 0001104659-23-129247.txt   5475
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Issuer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 U.S. 9 SUITE 500 MANALAPAN TOWNSHIP NJ 07726
Business Address
Bradley Greg (Reporting) CIK: 0001833504 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39752 | Film No.: 231513920